BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38905325)

  • 1. MAIT cells monitor intestinal dysbiosis and contribute to host protection during colitis.
    El Morr Y; Fürstenheim M; Mestdagh M; Franciszkiewicz K; Salou M; Morvan C; Dupré T; Vorobev A; Jneid B; Premel V; Darbois A; Perrin L; Mondot S; Colombeau L; Bugaut H; du Halgouet A; Richon S; Procopio E; Maurin M; Philippe C; Rodriguez R; Lantz O; Legoux F
    Sci Immunol; 2024 Jun; 9(96):eadi8954. PubMed ID: 38905325
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mucosal-associated invariant T-Cell (MAIT) activation is altered by chlorpyrifos- and glyphosate-treated commensal gut bacteria.
    Mendler A; Geier F; Haange SB; Pierzchalski A; Krause JL; Nijenhuis I; Froment J; Jehmlich N; Berger U; Ackermann G; Rolle-Kampczyk U; von Bergen M; Herberth G
    J Immunotoxicol; 2020 Dec; 17(1):10-20. PubMed ID: 31909636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alcohol-associated intestinal dysbiosis alters mucosal-associated invariant T-cell phenotype and function.
    Gu M; Samuelson DR; Taylor CM; Molina PE; Luo M; Siggins RW; Shellito JE; Welsh DA
    Alcohol Clin Exp Res; 2021 May; 45(5):934-947. PubMed ID: 33704802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
    Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
    Front Immunol; 2021; 12():720354. PubMed ID: 34539656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity.
    Toubal A; Kiaf B; Beaudoin L; Cagninacci L; Rhimi M; Fruchet B; da Silva J; Corbett AJ; Simoni Y; Lantz O; Rossjohn J; McCluskey J; Lesnik P; Maguin E; Lehuen A
    Nat Commun; 2020 Jul; 11(1):3755. PubMed ID: 32709874
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MAIT cells and the microbiome.
    Jabeen MF; Hinks TSC
    Front Immunol; 2023; 14():1127588. PubMed ID: 36911683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Augmentation of the Riboflavin-Biosynthetic Pathway Enhances Mucosa-Associated Invariant T (MAIT) Cell Activation and Diminishes Mycobacterium tuberculosis Virulence.
    Dey RJ; Dey B; Harriff M; Canfield ET; Lewinsohn DM; Bishai WR
    mBio; 2021 Feb; 13(1):e0386521. PubMed ID: 35164552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of bacterial metabolism by the microenvironment controls MAIT cell stimulation.
    Schmaler M; Colone A; Spagnuolo J; Zimmermann M; Lepore M; Kalinichenko A; Bhatia S; Cottier F; Rutishauser T; Pavelka N; Egli A; Azzali E; Pieroni M; Costantino G; Hruz P; Sauer U; Mori L; De Libero G
    Mucosal Immunol; 2018 Jul; 11(4):1060-1070. PubMed ID: 29743612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Jα33+ MAIT cells play a protective role in TNBS induced intestinal inflammation.
    Ruijing X; Mengjun W; Xiaoling Z; Shu P; Mei W; Yingcheng Z; Yuling H; Jinquan T
    Hepatogastroenterology; 2012 May; 59(115):762-7. PubMed ID: 22115767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An inhibitory immunoreceptor Allergin-1 regulates the intestinal dysbiosis and barrier function in mice.
    Lin YH; Tahara-Hanaoka S; Obana N; Fukuda S; Shibuya A
    Int Immunol; 2024 Jun; 36(7):365-371. PubMed ID: 38442194
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes.
    Rouxel O; Da Silva J; Beaudoin L; Nel I; Tard C; Cagninacci L; Kiaf B; Oshima M; Diedisheim M; Salou M; Corbett A; Rossjohn J; McCluskey J; Scharfmann R; Battaglia M; Polak M; Lantz O; Beltrand J; Lehuen A
    Nat Immunol; 2017 Dec; 18(12):1321-1331. PubMed ID: 28991267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated Mucosal-associated Invariant T Cells Have a Pathogenic Role in a Murine Model of Inflammatory Bowel Disease.
    Yasutomi Y; Chiba A; Haga K; Murayama G; Makiyama A; Kuga T; Watanabe M; Okamoto R; Nagahara A; Nagaishi T; Miyake S
    Cell Mol Gastroenterol Hepatol; 2022; 13(1):81-93. PubMed ID: 34461283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class I-related molecule, MR1, and mucosal-associated invariant T cells.
    Franciszkiewicz K; Salou M; Legoux F; Zhou Q; Cui Y; Bessoles S; Lantz O
    Immunol Rev; 2016 Jul; 272(1):120-38. PubMed ID: 27319347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MAIT cells are activated and accumulated in the inflamed mucosa of ulcerative colitis.
    Haga K; Chiba A; Shibuya T; Osada T; Ishikawa D; Kodani T; Nomura O; Watanabe S; Miyake S
    J Gastroenterol Hepatol; 2016 May; 31(5):965-72. PubMed ID: 26590105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recipient mucosal-associated invariant T cells control GVHD within the colon.
    Varelias A; Bunting MD; Ormerod KL; Koyama M; Olver SD; Straube J; Kuns RD; Robb RJ; Henden AS; Cooper L; Lachner N; Gartlan KH; Lantz O; Kjer-Nielsen L; Mak JY; Fairlie DP; Clouston AD; McCluskey J; Rossjohn J; Lane SW; Hugenholtz P; Hill GR
    J Clin Invest; 2018 May; 128(5):1919-1936. PubMed ID: 29629900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.
    Sasson SC; Zaunders JJ; Nahar K; Munier CML; Fairfax BP; Olsson-Brown A; Jolly C; Read SA; Ahlenstiel G; Palendira U; Scolyer RA; Carlino MS; Payne MJ; Cheung VTF; Gupta T; Klenerman P; Long GV; Brain O; Menzies AM; Kelleher AD
    Clin Exp Immunol; 2020 Dec; 202(3):335-352. PubMed ID: 32734627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transferable Immunoglobulin A-Coated Odoribacter splanchnicus in Responders to Fecal Microbiota Transplantation for Ulcerative Colitis Limits Colonic Inflammation.
    Lima SF; Gogokhia L; Viladomiu M; Chou L; Putzel G; Jin WB; Pires S; Guo CJ; Gerardin Y; Crawford CV; Jacob V; Scherl E; Brown SE; Hambor J; Longman RS
    Gastroenterology; 2022 Jan; 162(1):166-178. PubMed ID: 34606847
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucosal-associated invariant T-cell activation and accumulation after in vivo infection depends on microbial riboflavin synthesis and co-stimulatory signals.
    Chen Z; Wang H; D'Souza C; Sun S; Kostenko L; Eckle SB; Meehan BS; Jackson DC; Strugnell RA; Cao H; Wang N; Fairlie DP; Liu L; Godfrey DI; Rossjohn J; McCluskey J; Corbett AJ
    Mucosal Immunol; 2017 Jan; 10(1):58-68. PubMed ID: 27143301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationally designed bacterial consortia to treat chronic immune-mediated colitis and restore intestinal homeostasis.
    van der Lelie D; Oka A; Taghavi S; Umeno J; Fan TJ; Merrell KE; Watson SD; Ouellette L; Liu B; Awoniyi M; Lai Y; Chi L; Lu K; Henry CS; Sartor RB
    Nat Commun; 2021 May; 12(1):3105. PubMed ID: 34050144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mucosa-associated invariant T cells link intestinal immunity with antibacterial immune defects in alcoholic liver disease.
    Riva A; Patel V; Kurioka A; Jeffery HC; Wright G; Tarff S; Shawcross D; Ryan JM; Evans A; Azarian S; Bajaj JS; Fagan A; Patel V; Mehta K; Lopez C; Simonova M; Katzarov K; Hadzhiolova T; Pavlova S; Wendon JA; Oo YH; Klenerman P; Williams R; Chokshi S
    Gut; 2018 May; 67(5):918-930. PubMed ID: 29097439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.